Sale!

ALG8 Gene Glycosylation Disorder Type 1H Genetic Test

Original price was: $700.Current price is: $500.

-29%

The ALG8 Gene Glycosylation Disorder Type 1H NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the ALG8 gene responsible for congenital disorders of glycosylation. This comprehensive test utilizes next-generation sequencing technology to detect specific genetic variations that disrupt normal protein glycosylation processes, leading to metabolic disorders. Patients experiencing developmental delays, neurological symptoms, or unexplained metabolic abnormalities should consider this test. The analysis provides crucial information for accurate diagnosis, personalized treatment strategies, and family planning decisions. With results available in 3-4 weeks from blood or DNA samples, this test offers valuable insights into rare metabolic conditions. The test is priced at $500 USD with genetic counseling included.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

ALG8 Gene Glycosylation Disorder Type 1H NGS Genetic DNA Test

Comprehensive Genetic Testing for Metabolic Disorders

The ALG8 Gene Glycosylation Disorder Type 1H NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare metabolic conditions. This advanced genetic screening utilizes next-generation sequencing (NGS) technology to identify specific mutations in the ALG8 gene that disrupt normal glycosylation processes essential for proper cellular function and development.

What is Glycosylation and Why Does It Matter?

Glycosylation is a critical biological process where sugar molecules (glycans) are attached to proteins and lipids, creating glycoproteins and glycolipids. These complex molecules play vital roles in cell signaling, immune function, protein stability, and intercellular communication. When glycosylation processes are disrupted due to ALG8 gene mutations, it leads to Congenital Disorders of Glycosylation Type 1H (CDG-1H), a serious metabolic condition affecting multiple organ systems.

What the Test Detects and Measures

Our comprehensive NGS genetic test specifically targets:

  • Complete sequencing of the ALG8 gene to identify pathogenic variants
  • Detection of missense, nonsense, frameshift, and splice-site mutations
  • Analysis of genetic variations affecting dolichol-linked oligosaccharide biosynthesis
  • Identification of autosomal recessive inheritance patterns
  • Assessment of mutation impact on ALG8 enzyme function

Advanced NGS Technology for Maximum Accuracy

Utilizing state-of-the-art next-generation sequencing platforms, our test achieves over 99% accuracy in detecting ALG8 gene mutations. The comprehensive analysis covers all coding regions, splice sites, and known regulatory elements, ensuring no significant variants are missed.

Who Should Consider This Genetic Test?

This test is particularly recommended for individuals presenting with:

Clinical Symptoms and Indications

  • Infants and children with unexplained developmental delays
  • Neurological abnormalities including seizures, hypotonia, or ataxia
  • Failure to thrive and growth retardation
  • Hepatic dysfunction and gastrointestinal issues
  • Coagulation disorders and abnormal bleeding tendencies
  • Dysmorphic facial features and skeletal abnormalities
  • Family history of metabolic disorders or consanguineous parents
  • Unexplained hypoglycemia or metabolic acidosis

Diagnostic Scenarios

Healthcare providers should consider this test when:

  • Routine metabolic screening reveals abnormal transferrin isoforms
  • Standard diagnostic approaches fail to identify the underlying cause
  • Multiple organ systems are affected without clear explanation
  • There’s a family history suggesting autosomal recessive inheritance

Significant Benefits of ALG8 Genetic Testing

Accurate Diagnosis and Personalized Care

  • Definitive Diagnosis: Provides conclusive genetic evidence for CDG-1H
  • Treatment Guidance: Enables targeted therapeutic interventions
  • Prognostic Information: Helps predict disease progression and outcomes
  • Family Planning: Assists in reproductive decision-making

Clinical Management Advantages

  • Early Intervention: Facilitates prompt treatment initiation
  • Multidisciplinary Care: Guides appropriate specialist referrals
  • Monitoring Strategies: Establishes baseline for ongoing assessment
  • Research Contribution: Advances understanding of rare metabolic diseases

Understanding Your Test Results

Interpretation Guidelines

Our comprehensive genetic report includes:

  • Positive Result: Identification of pathogenic ALG8 mutations confirms CDG-1H diagnosis and enables targeted management
  • Negative Result: Absence of detected mutations suggests alternative diagnoses should be considered
  • Variant of Uncertain Significance: Unknown genetic changes requiring further investigation and family studies
  • Carrier Status: Identification of individuals with single mutation copies who are typically asymptomatic

Post-Test Recommendations

  • Genetic counseling for comprehensive result interpretation
  • Family member testing when appropriate
  • Referral to metabolic specialists for ongoing management
  • Dietary and nutritional interventions as indicated
  • Regular monitoring for disease complications

Test Details and Pricing

Test Component Details Price (USD)
Test Name ALG8 Gene Glycosylation Disorder Type 1H NGS Genetic DNA Test
Discount Price Limited time special offer $500
Regular Price Standard pricing $700
Turnaround Time Comprehensive analysis period 3-4 Weeks
Sample Type Multiple collection options available Blood, Extracted DNA, or Blood on FTA Card

Pre-Test Requirements

Before testing, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session with our specialists
  • Development of detailed family pedigree chart
  • Discussion of testing implications and potential outcomes

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified collection centers ensures accessible testing regardless of your location.

Easy Sample Collection Process

Choose from multiple sample collection methods:

  • Blood Draw: Performed at our certified phlebotomy centers
  • Extracted DNA: Accept samples from your healthcare provider
  • FTA Card: Simple finger-prick method for convenient home collection

Take Control of Your Genetic Health Today

Don’t let uncertainty about metabolic symptoms delay proper diagnosis and treatment. Our ALG8 Gene Glycosylation Disorder Type 1H NGS Genetic DNA Test provides the definitive answers you need for informed healthcare decisions. With our advanced NGS technology and expert genetic analysis, you’ll receive comprehensive insights into potential metabolic disorders.

Ready to Schedule Your Test?

Contact our genetic specialists today to discuss your testing needs and schedule your appointment. Call us at +1(267) 388-9828 or use our convenient online booking system. Our team is available to answer your questions and guide you through the testing process with compassion and expertise.

Take the first step toward clarity and personalized care – book your ALG8 genetic test now and benefit from our limited-time discounted pricing of only $500 USD.